149 related articles for article (PubMed ID: 15652662)
1. Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan.
Ozaki T; Nishimura N; Muto T; Sugata K; Kawabe S; Goto K; Koyama K; Fujita H; Takahashi Y; Akiyama M
Vaccine; 2005 Jan; 23(10):1205-8. PubMed ID: 15652662
[TBL] [Abstract][Full Text] [Related]
2. Sensitization to gelatin in children with systemic non-immediate-type reactions to varicella vaccines.
Sakaguchi M; Miyazawa H; Inouye S
Ann Allergy Asthma Immunol; 2000 Mar; 84(3):341-4. PubMed ID: 10752920
[TBL] [Abstract][Full Text] [Related]
3. Systemic allergic reactions to gelatin included in vaccines as a stabilizer.
Sakaguchi M; Inouye S
Jpn J Infect Dis; 2000 Oct; 53(5):189-95. PubMed ID: 11135703
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
Ozaki T
Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.
Pool V; Braun MM; Kelso JM; Mootrey G; Chen RT; Yunginger JW; Jacobson RM; Gargiullo PM;
Pediatrics; 2002 Dec; 110(6):e71. PubMed ID: 12456938
[TBL] [Abstract][Full Text] [Related]
6. Reactogenicity and immunogenicity of a live-attenuated refrigerator-stable varicella vaccine (OKA strain) in healthy seronegative subjects age 10 months to 12 years.
Hadinegoro SR; Hindra IS; Han HH; Gatchalian S; Bock HL
Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):991-9. PubMed ID: 19842382
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
8. Immunization of HIV-infected children with varicella vaccine.
Levin MJ; Gershon AA; Weinberg A; Blanchard S; Nowak B; Palumbo P; Chan CY;
J Pediatr; 2001 Aug; 139(2):305-10. PubMed ID: 11487761
[TBL] [Abstract][Full Text] [Related]
9. A sero-epidemiological survey of gelatin sensitization in young Japanese children during the 1979-1996 period.
Saito A; Kumagai T; Kojima H; Terai I; Yamanaka T; Wataya Y; Umetsu M; Umetsu A; Yano S
Scand J Immunol; 2005 Apr; 61(4):376-9. PubMed ID: 15853922
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
[TBL] [Abstract][Full Text] [Related]
12. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
[TBL] [Abstract][Full Text] [Related]
13. Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines.
Kumagai T; Yamanaka T; Wataya Y; Umetsu A; Kawamura N; Ikeda K; Furukawa H; Kimura K; Chiba S; Saito S; Sugawara N; Kurimoto F; Sakaguchi M; Inouye S
J Allergy Clin Immunol; 1997 Jul; 100(1):130-4. PubMed ID: 9257797
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
[TBL] [Abstract][Full Text] [Related]
15. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
[TBL] [Abstract][Full Text] [Related]
16. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
Goh P; Lim FS; Han HH; Willems P
Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
20. Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group.
Furth SL; Hogg RJ; Tarver J; Moulton LH; Chan C; Fivush BA;
Pediatr Nephrol; 2003 Jan; 18(1):33-8. PubMed ID: 12488988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
